Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1981 3
1982 29
1983 18
1984 14
1985 29
1986 57
1987 71
1988 103
1989 121
1990 148
1991 134
1992 130
1993 142
1994 132
1995 104
1996 121
1997 117
1998 99
1999 91
2000 89
2001 86
2002 77
2003 94
2004 70
2005 73
2006 78
2007 76
2008 61
2009 80
2010 64
2011 60
2012 68
2013 78
2014 73
2015 79
2016 69
2017 50
2018 58
2019 60
2020 58
2021 60
2022 46
2023 59
2024 47
2025 55
2026 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,262 results

Results by year

Filters applied: . Clear all
Page 1
Buspirone: future directions.
Apter JT, Allen LA. Apter JT, et al. J Clin Psychopharmacol. 1999 Feb;19(1):86-93. doi: 10.1097/00004714-199902000-00014. J Clin Psychopharmacol. 1999. PMID: 9934947 Review.
The Food and Drug Administration approved the use of buspirone for generalized anxiety disorder (GAD) in 1986. Since then, numerous studies have examined the efficacy and safety of buspirone for patients with not only generalized feelings of anxiety, but also panic …
The Food and Drug Administration approved the use of buspirone for generalized anxiety disorder (GAD) in 1986. Since then, numerous s …
Anxiolytic antidepressant augmentation.
Sussman N. Sussman N. J Clin Psychiatry. 1998;59 Suppl 5:42-8; discussion 49-50. J Clin Psychiatry. 1998. PMID: 9635547 Review.
On the other hand, the anxiolytic agent buspirone does facilitate direct antidepressant response, largely through its ability to activate both presynaptic and postsynaptic 5-HT1A receptors and thus modulate serotonin release. Several case studies and open-label trials have …
On the other hand, the anxiolytic agent buspirone does facilitate direct antidepressant response, largely through its ability to acti …
Buspirone: Back to the Future.
Howland RH. Howland RH. J Psychosoc Nurs Ment Health Serv. 2015 Nov;53(11):21-4. doi: 10.3928/02793695-20151022-01. J Psychosoc Nurs Ment Health Serv. 2015. PMID: 26535760 Review.
Buspirone, first synthesized in 1968 and marketed in 1986, is a pharmacologically unique azapirone drug. ...Buspirone and melatonin may synergistically promote neurogenesis, supporting the potential use of this combination for treating depression and cognitive impai …
Buspirone, first synthesized in 1968 and marketed in 1986, is a pharmacologically unique azapirone drug. ...Buspirone and mela …
Buspirone-induced mania.
McIvor R, Sinanan K. McIvor R, et al. Br J Psychiatry. 1991 Jan;158:136-7. doi: 10.1192/bjp.158.1.136. Br J Psychiatry. 1991. PMID: 2015445 No abstract available.
Buspirone overdose.
Tiller JW, Burrows GD, O'Sullivan BT. Tiller JW, et al. Med J Aust. 1989 Jan 2;150(1):54. doi: 10.5694/j.1326-5377.1989.tb136355.x. Med J Aust. 1989. PMID: 2909855 No abstract available.
Buspirone-induced mania.
Price WA, Bielefeld M. Price WA, et al. J Clin Psychopharmacol. 1989 Apr;9(2):150-1. doi: 10.1097/00004714-198904000-00025. J Clin Psychopharmacol. 1989. PMID: 2723135 No abstract available.
Late-stage-functionalization of anti-depressant molecule buspirone.
Guo Y, Yang D, Hu B, Duan Y, Cheng Y, Tang Y, Guo C, Li Y, Yu B. Guo Y, et al. Mol Divers. 2025 Oct;29(5):5033-5043. doi: 10.1007/s11030-024-11029-x. Epub 2024 Nov 23. Mol Divers. 2025. PMID: 39578294 Review.
Buspirone, a well-established anxiolytic agent, has gained attention for its potential role as an antidepressant, primarily due to its unique pharmacological profile and the ability to modulate serotonin receptors effectively. ...This review summarizes various late-stage f …
Buspirone, a well-established anxiolytic agent, has gained attention for its potential role as an antidepressant, primarily due to it …
Buspirone in clinical practice.
Rickels K. Rickels K. J Clin Psychiatry. 1990 Sep;51 Suppl:51-4. J Clin Psychiatry. 1990. PMID: 2211569 Review.
Buspirone, an azapirone derivative and a 5-HT1A partial agonist, is the first nonbenzodiazepine anxiolytic introduced into medicine for the treatment of generalized anxiety disorder. ...Slower and more gradual onset of anxiety relief is balanced by the increased safety and …
Buspirone, an azapirone derivative and a 5-HT1A partial agonist, is the first nonbenzodiazepine anxiolytic introduced into medicine f …
Adverse events related to buspirone: a real-world pharmacovigilance study using the FAERS database.
Wen Z, Liu X, Guo P, Wang C, Xu X, Liu P. Wen Z, et al. J Affect Disord. 2026 May 15;401:121240. doi: 10.1016/j.jad.2026.121240. Epub 2026 Jan 31. J Affect Disord. 2026. PMID: 41628752
Buspirone, a widely used anxiolytic, has incompletely characterized adverse effects. This study aimed to comprehensively characterize buspirone's safety profile by a large-scale analysis of real-world data from the Food and Drug Administration Adverse Event R …
Buspirone, a widely used anxiolytic, has incompletely characterized adverse effects. This study aimed to comprehensively characterize …
3,262 results